Validation of the French version of the Compliance Questionnaire for Rheumatology (CQR-5), a self-reporting questionnaire specific to patients with chronic inflammatory rheumatic disease - 19/11/22
Doi : 10.1016/j.jbspin.2022.105449
Pauline Cavagna a, ⁎ 
, Julien Hubert a, Cécile Bottois a, Clementina Lopez-Medina b, c, Christian Roux b, d, Ornella Conort a, Maxime Dougados b, d
, Julien Hubert a, Cécile Bottois a, Clementina Lopez-Medina b, c, Christian Roux b, d, Ornella Conort a, Maxime Dougados b, d a Université de Paris, AP–HP, centre département de pharmacie clinique - hôpital Cochin, 27, rue du Faubourg Saint-Jacques, 75014 Paris, France
b Université de Paris, AP–HP, centre département de rhumatologie - hôpital Cochin, Paris, France
c Rheumatology Department, Reina Sofia University Hospital, IMIBIC, University of Cordoba, Cordoba, Spain
d INSERM (U1153), Clinical epidemiology and biostatistics, PRESS Sorbonne Paris-Cité, Paris, France
⁎Corresponding author.
Highlights |
• | The CQR5 was developed for easier and faster use in clinical practice. |
• | The CQR5 is a validated english tool for patients with inflammatory arthritis. |
• | The French CQR5 questionnaire was one-dimensional, reproducible and reliable. |
• | The French CQR5 is a free questionnaire. |
• | The French CQR5 is a validated tool to assess adherence to bDMARDs. |
Keywords : Medication adherence, Compliance, Questionnaire, Biologic disease-modifying anti-rheumatic drugs, French validation
Mappa
© 2022
Société française de rhumatologie. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 89 - N° 6
Articolo 105449- novembre 2022 Ritorno al numero
Articolo precedente
- Polymyalgia rheumatica associated with primary Sjögren's syndrome: A French multicentric retrospective study
- Sara Boukhlal, Renaud Felten, Elisabeth Gervais, Bruno Grardel, Yoann Le Cam, Jacques-Eric Gottenberg, Alain Saraux, Valérie Devauchelle-Pensec
- Anti-MDA5 antibody-associated clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease
- Taro Horino, Satoshi Inotani, Kimiko Nakajima, Hiroshi Ohnishi, Masahiro Komori, Yoshio Terada
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?